Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Ospedali Riuniti di Bergamo Case Western Reserve University Medtronic |
---|---|
Information provided by: | Ospedali Riuniti di Bergamo |
ClinicalTrials.gov Identifier: | NCT00704561 |
The objective of this study is to evaluate the completeness of struts coverage and vessel wall response (strut malapposition, neointima disomogeneities in texture) to the ENDEAVOR drug-eluting stent vs the DRIVER stent (bare metal stent of identical metallic platform) implanted for the treatment of the culprit lesion in ST-elevation acute myocardial infarction (STEMI). To investigate the completeness of the coverage as well as the number of uncovered stent struts per section (embedded, uncovered, malapposed) and the neointima texture, high resolution (~ 10-15 µm axial) intracoronary optical coherence tomography (OCT)will be used.
Condition | Intervention | Phase |
---|---|---|
Acute Myocardial Infarction |
Device: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA) Device: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Prospective, Randomized, Controlled Arm Study Comparing the Coverage of the Zotarolimus-Eluting Stent vs Bare Metal Stent Implanted in ST- Elevation Myocardial Infarction (STEMI). |
Estimated Enrollment: | 40 |
Study Start Date: | April 2008 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Zotarolimus drug-eluting stent
|
Device: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA)
ENDEAVOR® drug-eluting stent implanted in acute myocardial infarction
|
2: Active Comparator
bare metal stent
|
Device: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca)
DRIVER bare metal stent implanted in acute myocardial infarction
|
Major concerns have been raised with regard to the safety of drug-eluting stents (DES) in patients with ST-elevation acute myocardial infarction (STEMI). Data from registry studies have suggested that implantation of DES during primary PCI could be associated with an increased risk for stent thrombosis, probably due to delayed arterial healing. Unlike first generation DES, zotarolimus-eluting stents seems to be associated with complete and uniform neointimal coverage. The objective of this prospective study is to measure the completeness of strut coverage and vessel wall response to the ENDEAVOR zotarolimus-eluting stent vs the DRIVER stent (bare metal stent of identical metallic platform) implanted in STEMI patients. Optical Coherence Tomography (OCT) that detects smaller degrees of stent strut coverage more accurately than IVUS will be used at 6 months follow-up. Intravascular ultrasound (IVUS) will be performed as per normal practice at any index procedures and at 6 months follow-up.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Monia Lorini, MD | 39-035-269-751 | mlorini@ospedaliriuniti.bergamo.it |
Italy | |
Ospedali Riuniti di Bergamo | Recruiting |
Bergamo, Italy | |
Contact: Giulio Guagliumi, MD 39-035-266-455 guagliumig@interfree.it | |
Contact: Giuseppe Musumeci, MD 39-035-266-455 giuseppe.musumeci@gmail.it |
Principal Investigator: | Giulio Guagliumi, MD | Cardiovascular Department Ospedali Riuniti di Bergamo |
Responsible Party: | Ospedali Riuniti di Bergamo ( Giulio Guagliumi ) |
Study ID Numbers: | 457/2008 |
Study First Received: | June 24, 2008 |
Last Updated: | June 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00704561 |
Health Authority: | Italy: Ethics Committee |
Acute Myocardial Infarction Percutaneous Coronary Interventions Optical Coherence Tomography Thrombus |
Necrosis Heart Diseases Myocardial Ischemia Vascular Diseases |
Ischemia Infarction Myocardial Infarction Thrombosis |
Pathologic Processes Cardiovascular Diseases |